Processa Pharmaceuticals Inc. (PCSA) mentioned long at newsletter
- Earnings put floor under European stocks, COVID cases in Asia eyed
- Netflix (NFLX) Tops Q1 EPS by 78c, Subs Miss
- Oil prices drop as India's COVID-19 surge dents demand outlook
- Dollar struggles to recover after slump to 7-week trough amid lower U.S. yields
- Manchester United (MANU) Stock Falls as European Super League Collapses Amid Huge Fans Backlash
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Processa Pharmaceuticals Inc. (NASDAQ: PCSA) mentioned long at newsletter, $15 target.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Companies with NDRs 4/20
- PetIQ, Inc. (PETQ) Gains on Barron's Pump
- Axon (AXON), Digital Ally (DGLY) Lower Following Chauvin Guilty Verdict